<?xml version="1.0"?><rss version="2.0">
<channel>
<title>Pharma Misbehaving from Newser</title>
<description></description>
<link>http://www.newser.com/</link>
<copyright>2007 - Newser</copyright>
<language>en-us</language>
<generator>Newser Feed Generator</generator>
<pubDate>Sat, 17 May 2008 00:53:08 CDT </pubDate>

    <item>
        <guid isPermaLink="true">  http://www.newser.com/story/27488.html?rss=y </guid>
        <title><![CDATA[  Court Tosses $32M   Verdict Against Vioxx ]]></title>
        <description><![CDATA[A Texas appellate court threw out a $32 million verdict against Merck today, citing a lack of evidence that Vioxx contributed to a man&rsquo;s fatal heart attack. Lionel Garza was taking the painkiller when he died in 2001 at age 71, but was also a smoker with high blood pressure and high cholesterol, the Wall Street Journal reports. The Garza case was decided by verdict in 2006, and was excluded from a recent $4.85 billion settlement for 27,000 Vioxx cases.]]></description>
        <link> http://www.newser.com/story/27488.html?rss=y </link>
        <pubDate> Wed, 14 May 2008 13:29:37 CDT  </pubDate>
    </item>
    <item>
        <guid isPermaLink="true">  http://www.newser.com/story/26924.html?rss=y </guid>
        <title><![CDATA[ 'Experts' Too Often Feeding From Industry Troughs]]></title>
        <description><![CDATA[Media consumers, beware: that assertive, well-versed, trustworthy &quot;expert&quot; may in fact be an industry shill, Shannon Brownlee and Jeanne Lenzer write on Slate. Journalists across the board, and even some radio hosts, are failing to disclose financial ties to various industries&mdash;drug companies being a prime example&mdash;fudging the line between considered opinion and paid advocacy.]]></description>
        <link> http://www.newser.com/story/26924.html?rss=y </link>
        <pubDate> Thu, 08 May 2008 18:41:40 CDT  </pubDate>
    </item>
    <item>
        <guid isPermaLink="true">  http://www.newser.com/story/26848.html?rss=y </guid>
        <title><![CDATA[ Congress to Probe 'Misleading' Drug Ads]]></title>
        <description><![CDATA[A congressional panel will examine three ad campaigns as part of a move to tighten regulations on drug companies' direct-to-consumer marketing, the Wall Street Journal reports. The committee will focus on ads for cholesterol drugs Vytorin and Lipitor, and anemia drug Procrit, which has been promoted as an anti-fatigue drug despite FDA demands not to do so.]]></description>
        <link> http://www.newser.com/story/26848.html?rss=y </link>
        <pubDate> Thu, 08 May 2008 03:10:00 CDT  </pubDate>
    </item>
    <item>
        <guid isPermaLink="true">  http://www.newser.com/story/25923.html?rss=y </guid>
        <title><![CDATA[ Despite Danger, FDA Sanctioned Artificial Blood Studies]]></title>
        <description><![CDATA[The Food and Drug Administration repeatedly approved experiments using artificial blood despite data showing the products to be dangerous, the Washington Post reports. Investigators from the National Institutes of Health found heart attack risk tripled and death increased by 30% for subjects in 16 studies testing five kinds of artificial blood, which, it is hoped, will ultimately provide alternative transfusions.]]></description>
        <link> http://www.newser.com/story/25923.html?rss=y </link>
        <pubDate> Mon, 28 Apr 2008 13:50:09 CDT  </pubDate>
    </item>
    <item>
        <guid isPermaLink="true">  http://www.newser.com/story/25263.html?rss=y </guid>
        <title><![CDATA[ Deadly Heparin Found in 11 Nations]]></title>
        <description><![CDATA[The FDA has traced a contaminated blood thinner from a Chinese factory to 11 countries, the New York Times reports. Severe reactions to the contaminated heparin have been linked to the deaths of 81 Americans, but it wasn't immediately clear if the drug may have triggered fatalities in other countries. Chinese officials have denied that the contamination caused any deaths and have demanded to be allowed to inspect the US plant where the heparin was packaged.]]></description>
        <link> http://www.newser.com/story/25263.html?rss=y </link>
        <pubDate> Tue, 22 Apr 2008 07:17:00 CDT  </pubDate>
    </item>
    <item>
        <guid isPermaLink="true">  http://www.newser.com/story/24606.html?rss=y </guid>
        <title><![CDATA[ Merck Used Ghostwriters to Draft Rosy Vioxx Studies]]></title>
        <description><![CDATA[Merck used its own ghostwriters to draft articles minimizing risks of its drug Vioxx, then found medical researchers to lend their names to the research, the Wall Street Journal reports. Merck, which pulled the painkiller from shelves four years ago over heart-attack risks, rejects the claims as &quot;misleading.&quot; They appear in tomorrow's edition of the Journal of the American Medical Association.]]></description>
        <link> http://www.newser.com/story/24606.html?rss=y </link>
        <pubDate> Tue, 15 Apr 2008 19:51:25 CDT  </pubDate>
    </item>
    <item>
        <guid isPermaLink="true">  http://www.newser.com/story/24231.html?rss=y </guid>
        <title><![CDATA[ Doc: Merck Fudged Minutes of Meeting]]></title>
        <description><![CDATA[Merck's &quot;minutes&quot; of a meeting of heart doctors discussing cholesterol drug Vytorin were created a month after the meeting and distorted the viewpoints of the experts, one panel member changes. The drug company submitted the document to congressional investigators probing its two-year delay in releasing a report saying the drug didn't work any better than a much cheaper generic one, Bloomberg reports.]]></description>
        <link> http://www.newser.com/story/24231.html?rss=y </link>
        <pubDate> Sat, 12 Apr 2008 09:33:25 CDT  </pubDate>
    </item>
    <item>
        <guid isPermaLink="true">  http://www.newser.com/story/23577.html?rss=y </guid>
        <title><![CDATA[ J&amp;J Hid Birth Control Patch Risks: Suit]]></title>
        <description><![CDATA[Johnson &amp; Johnson doctored data to get its birth control patch FDA-approved, according to a class action lawsuit that claims Ortho-Evra caused blood clots, heart attacks, and strokes. A J&amp;J scientist allegedly doctored the data with a &quot;correction factor&quot; for the FDA, lowering estrogen-related risk by 60%: He &quot;presented a truly misleading picture of the amount of estrogen delivered by the patch,'' the suit said.]]></description>
        <link> http://www.newser.com/story/23577.html?rss=y </link>
        <pubDate> Sun, 06 Apr 2008 16:40:00 CDT  </pubDate>
    </item>
    <item>
        <guid isPermaLink="true">  http://www.newser.com/story/23107.html?rss=y </guid>
        <title><![CDATA[ Firms Hid Bad News on  Heart Drugs 2 Years: Doc]]></title>
        <description><![CDATA[A scientist hired by two drug companies to conduct trials of cholesterol-lowering drugs accused the firms of deliberately delaying release of the results, the New York Times reports. The results for the Vytorin and Zetia trials&mdash;which showed the drugs don't work to reduce plaque in arteries&mdash;were not released until almost two years after the medical trials wrapped up.&nbsp;]]></description>
        <link> http://www.newser.com/story/23107.html?rss=y </link>
        <pubDate> Tue, 01 Apr 2008 10:49:00 CDT  </pubDate>
    </item>
    <item>
        <guid isPermaLink="true">  http://www.newser.com/story/21989.html?rss=y </guid>
        <title><![CDATA[ Feds ID Extra Drug in Baxter's Recalled Heparin]]></title>
        <description><![CDATA[The Food and Drug Administration has identified the extra ingredient found in samples of Baxter&rsquo;s blood-thinning drug heparin, the Wall Street Journal reports today. Some batches of the drug&mdash;recalled in January after reports of allergic reactions&mdash;contained over-sulfated chondroitin sulfate, but it is not certain that was the cause of the hundreds of reactions or 19 deaths linked to Baxter&rsquo;s product.]]></description>
        <link> http://www.newser.com/story/21989.html?rss=y </link>
        <pubDate> Wed, 19 Mar 2008 13:44:43 CDT  </pubDate>
    </item>
</channel>
</rss>
